The pharmacokinetics of octreotide in cirrhosis and in healthy man
- 1 May 1997
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 26 (5) , 1018-1025
- https://doi.org/10.1016/s0168-8278(97)80110-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Sclerotherapy with or without Octreotide for Acute Variceal BleedingNew England Journal of Medicine, 1995
- Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertensionJournal of Hepatology, 1994
- Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis Emergency control and prevention of early rebleedingJournal of Molecular Medicine, 1994
- Octreotide infusion or emergency sclerotherapy for variceal haemorrhageThe Lancet, 1993
- A randomized comparison of intranasal and injectable octreotide administration in patients with acromegalyJournal of Clinical Endocrinology & Metabolism, 1992
- A Study of Octreotide in Oesophageal VaricesDigestion, 1990
- Endocrine profile of a long-acting somatostatin derivative SMS 201–995. Study in normal volunteers following subcutaneous administrationActa Endocrinologica, 1986
- Pharmacokinetics of SMS 201-995 in Healthy SubjectsScandinavian Journal of Gastroenterology, 1986
- The Somatostatin Analog SMS 201-995 Induces Long-Acting Inhibition of Growth Hormone Secretion without Rebound Hypersecretion in Acromegalic Patients*Journal of Clinical Endocrinology & Metabolism, 1985
- Comparison of Intravenous Somatostatin and Vasopressin Infusions in Treatment of Acute Variceal Hemorrhage†Hepatology, 1984